|
|
|
| Correlation on Detection of Low Density Lipoprotein Cholesterol and Plasma D-dimer Levels in Patients with Coronary Heart Disease |
| ZHU Yanzhong, SONG Cheng |
| The Taihu Rehabilitation Hospital of Jiangsu Province, Jiangsu Wuxi 214068, China |
|
|
|
|
Abstract Objective: To study the clinical value of pediatric low density lipoprotein cholesterol (sdLDL-C) and plasma D-dimer levels in physical examination of coronary heart disease patients. Methods: A total of 200 patients with coronary artery disease diagnosed in our hospital from October 2015 to October 2017 were selected as the observation group, including 66 patients with unstable angina (UAP), 56 patients with myocardial infarction (AMI), and stable angina pectoris. 78 patients (SAP) were included in the same period as 50 control subjects. The total cholesterol (TC), triglyceride (TG), serum sdLDL-C, and high-density lipoprotein cholesterol (HDL-C) were measured. Low-density lipoprotein cholesterol (LDL-C), plasma D-dimer and homocysteine (Hcy) levels. Results: The levels of TC, TG, serum sdLDL-C, LDL-C, HDL-C, Hcy and plasma D-dimer in the observation group were significantly higher than those in the control group (P<0.05). The comparison between the AMI group and the SAP group showed that the levels of sdLDL-C and D-dimer were significantly higher than those of the SAP group (P<0.05). The comparison between the UAP group and the SAP group showed no significant difference in the level of sdLDL-C. (P>0.05), but at the D-dimer level, UAP group was significantly higher than SAP group (P<0.05); AMI and UAP group data showed that there was no significant difference in sdLDL-C level (P>0.05) In addition, the comparison showed that D-dimer levels were higher than those in the UAP group (P<0.05). Conclusion: Detection of sdLDL-C and D-dimer can effectively reflect the specific condition of patients with coronary heart disease, and have important application value for the early diagnosis and prediction of coronary heart disease and clinical classification.
|
|
|
|
|
|
[1] Hirayama S ,Miida T .Small dense LDL :an emerging riskfactor for cardiovascular disease [J].Clin Chim Acta,2012,414:215~224.
[2] Toft-Petersen AP ,Tilsted HH ,Aare J ,et al .Smalldense LDL particles-a predictor of coronary artery dis-ease evaluated by invasive and CT-based techniques :acase-control study[J].Lipids Health Dis,2011,10(1):1~7.
[3] Lowe G ,Rumley A .The relevance of coagulation in cardi-ovascular disease :what do the biomarkers tell us[J].Thromb Haemost,2014,112(5):860~867.
[4] 王晓蕊,黄彩云,苗昌荣,等.超敏C-反应蛋白脂蛋白a及D-二聚体在脑梗死合并冠心病患者诊断中的价值[J].中国实用神经疾病杂志,2015(10):76~77.
[5] Expert Panel on Detection ,Evaluation ,and Treatment ofHigh Blood Cholesterol in Adults .Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection ,evaluation and treatment of high blood cholesterol in adults (A-dult Treatment Panel Ⅲ )[J].JAMA,2001,285(19):2486~2497.
[6] Hoogeveen RC ,Gaubatz JW ,Sun W ,et al .Small denselow-density lipoprotein-cholesterol concentrations predictrisk for coronary heart disease :the Atherosclerosis RiskIn Communities (ARIC) study[J].Arterioscler ThrombVasc Biol,2014,34(5):1069~1077.
[7] 魏丽. 超敏C-反应蛋白、脂蛋白(a)及D-二聚体检测在冠心病早期诊断中的应用价值[J].中国卫生标准管理,2016,7(19):133~134.
[8] 欧阳玉立,鲍曼.Hcy、hsCRP、LP(a)和D-D联合检测在冠心病诊断中的应用价值[J].江苏医药,2016,42(9):1074~1075. |
|
|
|
2019, Vol. 25 
